Fighting Superbugs: Supporting FDA Approval of a New Antibiotic

One of the most rewarding parts of leading Certara’s consulting services is recognizing how our work supports new drug approvals to positively impact patients’ health. In this blog post, I’ll discuss how Certara helped Cubist obtain FDA approval for Zerbaxa™ (ceftolozane/tazobactam), a new antibacterial drug to treat adults with complicated infections. The growing threat of … Continued

1 of 1
Back to top
Powered by GlobalLink OneLink Software